QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis
USA - NASDAQ:QDEL - US2197981051 - Common Stock
29.74 USD
+1.01 (+3.52%)
29.74 USD
0 (0%)
Taking everything into account, QDEL scores 4 out of 10 in our fundamental rating. QDEL was compared to 191 industry peers in the Health Care Equipment & Supplies industry. QDEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. QDEL is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year QDEL was profitable.
In the past year QDEL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: QDEL reported negative net income in multiple years.
QDEL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QDEL has a Return On Assets of -7.31%. This is in the better half of the industry: QDEL outperforms 65.44% of its industry peers.
With a decent Return On Equity value of -16.70%, QDEL is doing good in the industry, outperforming 62.30% of the companies in the same industry.
With a decent Return On Invested Capital value of 1.72%, QDEL is doing good in the industry, outperforming 69.11% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 8.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.31% | ||
| ROE | -16.7% | ||
| ROIC | 1.72% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
1.3 Margins
QDEL has a Operating Margin of 4.15%. This is in the better half of the industry: QDEL outperforms 68.59% of its industry peers.
In the last couple of years the Operating Margin of QDEL has declined.
QDEL's Gross Margin of 47.29% is in line compared to the rest of the industry. QDEL outperforms 41.88% of its industry peers.
QDEL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.15% | ||
| PM (TTM) | N/A | ||
| GM | 47.29% |
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
2. Health
2.1 Basic Checks
QDEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QDEL has more shares outstanding than it did 1 year ago.
QDEL has more shares outstanding than it did 5 years ago.
QDEL has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.81, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
QDEL has a Altman-Z score (0.81) which is in line with its industry peers.
QDEL has a debt to FCF ratio of 200.49. This is a negative value and a sign of low solvency as QDEL would need 200.49 years to pay back of all of its debts.
QDEL has a better Debt to FCF ratio (200.49) than 65.44% of its industry peers.
QDEL has a Debt/Equity ratio of 0.74. This is a neutral value indicating QDEL is somewhat dependend on debt financing.
QDEL has a worse Debt to Equity ratio (0.74) than 72.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 200.49 | ||
| Altman-Z | 0.81 |
ROIC/WACC0.23
WACC7.44%
2.3 Liquidity
QDEL has a Current Ratio of 1.12. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.12, QDEL is not doing good in the industry: 84.82% of the companies in the same industry are doing better.
QDEL has a Quick Ratio of 1.12. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
QDEL's Quick ratio of 0.62 is on the low side compared to the rest of the industry. QDEL is outperformed by 90.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
QDEL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.10%.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
The Revenue has decreased by -3.28% in the past year.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-4.1%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%271.43%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.63%
3.2 Future
QDEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.45% yearly.
Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 1.95% on average per year.
EPS Next Y31.32%
EPS Next 2Y33.68%
EPS Next 3Y32.36%
EPS Next 5Y24.45%
Revenue Next Year-2.4%
Revenue Next 2Y0.28%
Revenue Next 3Y1.82%
Revenue Next 5Y1.95%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.71, the valuation of QDEL can be described as correct.
Based on the Price/Earnings ratio, QDEL is valued cheaper than 90.58% of the companies in the same industry.
QDEL is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.00, which indicates a very decent valuation of QDEL.
94.24% of the companies in the same industry are more expensive than QDEL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.88. QDEL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.71 | ||
| Fwd PE | 9 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 95.29% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QDEL indicates a somewhat cheap valuation: QDEL is cheaper than 69.11% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 155.33 | ||
| EV/EBITDA | 7.96 |
4.3 Compensation for Growth
QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL's earnings are expected to grow with 32.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y33.68%
EPS Next 3Y32.36%
5. Dividend
5.1 Amount
QDEL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.74
+1.01 (+3.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.52%
Inst Owner Change5.72%
Ins Owners0.58%
Ins Owner Change2.36%
Market Cap2.02B
Analysts77.33
Price Target44.88 (50.91%)
Short Float %11.43%
Short Ratio5.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)357.74%
Min EPS beat(2)23.78%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)220.56%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)120.88%
EPS beat(12)10
Avg EPS beat(12)95.2%
EPS beat(16)13
Avg EPS beat(16)76.04%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)-1.51%
Revenue beat(4)1
Avg Revenue beat(4)1.81%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)11.02%
Revenue beat(8)4
Avg Revenue beat(8)0.22%
Revenue beat(12)8
Avg Revenue beat(12)2.33%
Revenue beat(16)11
Avg Revenue beat(16)4.56%
PT rev (1m)-10.2%
PT rev (3m)-12.5%
EPS NQ rev (1m)-20.46%
EPS NQ rev (3m)-30.51%
EPS NY rev (1m)-0.97%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)-2.28%
Revenue NQ rev (3m)-3.97%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.71 | ||
| Fwd PE | 9 | ||
| P/S | 0.74 | ||
| P/FCF | 155.33 | ||
| P/OCF | 10.08 | ||
| P/B | 0.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.96 |
EPS(TTM)2.34
EY7.87%
EPS(NY)3.31
Fwd EY11.12%
FCF(TTM)0.19
FCFY0.64%
OCF(TTM)2.95
OCFY9.92%
SpS40.38
BVpS41.13
TBVpS-8.53
PEG (NY)0.41
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.31% | ||
| ROE | -16.7% | ||
| ROCE | 2.17% | ||
| ROIC | 1.72% | ||
| ROICexc | 1.77% | ||
| ROICexgc | 5.25% | ||
| OM | 4.15% | ||
| PM (TTM) | N/A | ||
| GM | 47.29% | ||
| FCFM | 0.47% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 200.49 | ||
| Debt/EBITDA | 3.74 | ||
| Cap/Depr | 42.61% | ||
| Cap/Sales | 6.84% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 36.19% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 0.81 |
F-Score5
WACC7.44%
ROIC/WACC0.23
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.1%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%271.43%
EPS Next Y31.32%
EPS Next 2Y33.68%
EPS Next 3Y32.36%
EPS Next 5Y24.45%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.63%
Revenue Next Year-2.4%
Revenue Next 2Y0.28%
Revenue Next 3Y1.82%
Revenue Next 5Y1.95%
EBIT growth 1Y8.79%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year933.51%
EBIT Next 3Y133.77%
EBIT Next 5Y88.82%
FCF growth 1Y-88.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.98%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%